ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 2244 • 2015 ACR/ARHP Annual Meeting

    Risk of Incident Atrial Fibrillation in Gout

    Seoyoung C. Kim1, Jun Liu2 and Daniel H. Solomon3, 1Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Atrial fibrillation (AF) is the most common arrhythmia associated with cardiovascular disease and mortality. There are increasing data supporting the role of inflammation in…
  • Abstract Number: 915 • 2015 ACR/ARHP Annual Meeting

    Defining Pain for Fibromyalgia Criteria: Multi-Site or Widespread?  an Analysis of Data from Four UK Population-Based Studies

    Gary J. Macfarlane1, Linda E. Dean1, Robert Bennett2, Leslie J. Crofford3, Abimbola Ayorinde1, Elisa Fluess1, Daniel J. Clauw4, Mary-Ann Fitzcharles5, Don Goldenberg6, Eduardo Paiva7, Roland Staud8 and Lesley Arnold9, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2SN-Office of Research & Development, Oregon Health & Science Univ, Portland, OR, 3Medicine, Vanderbilt University, Nashville, TN, 4Anesthesiology, University of Michigan, Ann Arbor, MI, 5MGH, Montreal, QC, Canada, 6Newton-Wellesley Hospital, Newton, MA, 7Sociedade Brasileira de Reumatologia, São Paulo, Brazil, 8University of Florida, Gainesville, FL, 9University of Cincinnati, Cincinnati, OH

    Background/Purpose: The 1990 criteria for fibromyalgia (FM) remain the only set approved by the American College of Rheumatology (ACR). They require that pain be both…
  • Abstract Number: 2254 • 2015 ACR/ARHP Annual Meeting

    Socio-Economically Deprived Patients Have a Higher Likelihood for Having Any Type of Rheumatic and Musculoskeletal Diseases and Have Higher Healthcare Costs – Results from a Population-Based Administrative Database Including 1.9 Million Persons (Basque country, Spain)

    Polina Putrik1, Sofia Ramiro2, Jon Orueta3, Edurne Alonso Moran4, Roberto Nuno Solinis5 and Annelies Boonen6, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Centro de Salud de Astrabudua, Osakidetza, Basque Health Service, Erandio, Spain, 4O+berri, Basque Institute for Healthcare Innovation, Barakaldo, Spain, 5Universidad Deusto, Bilbao, Spain, 6Maastricht University Medical Center, Maastricht, Netherlands

    Background/Purpose: Rheumatic and musculoskeletal diseases (RMDs) are prevalent and have a strong impact on health care costs. Some evidence in specific diseases indicates that patients…
  • Abstract Number: 1069 • 2015 ACR/ARHP Annual Meeting

    Child’s HLA-DRB1 Genotype Increases Maternal Risk of Systemic Lupus Erythematosus: Results from the Mother-Child Immunogenetic Study in Autoimmunity

    Giovanna I. Cruz1, Xiaorong Shao2, Hong L. Quach2, Janelle Noble3, Nikolaos Patsopoulos4, Michael Busch5, Darrell Triulzi6, Wendy S.W. Wong7, Benjamin Solomon7, John Niederhuber7, Lindsey A. Criswell8 and Lisa F. Barcellos2, 1School of Public Health, University of California, Berkeley, Berkeley, CA, 2Genetic Epidemiology and Genomics Laboratory, University of California, Berkeley, Berkeley, CA, 3Children's Hospital Oakland Research Institute, Oakland, CA, 4Division of Genetics, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 5Blood Systems Research Institute, San Francisco, CA, 6Institute of Transfusion Medicine, University of Pittsburgh, Pittsburgh, PA, 7Division of Medical Genomics, Inova Translational Medicine Institute, Falls Church, VA, 8Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA

    Background/Purpose: SLE [MIM 152700] disproportionately affects women of reproductive age and pregnant patients are more likely to experience flares. Fetal microchimerism (FMC), or the persistence…
  • Abstract Number: 2284 • 2015 ACR/ARHP Annual Meeting

    Age and Sex Stratified Normative Data for Shoulder Range of Movement

    Tiffany K. Gill1, E. Michael Shanahan2,3, Graeme R Tucker1 and Catherine Hill4,5, 1Medicine, The University of Adelaide, Adelaide, Australia, 2Rheumatology, Flinders University, Bedford Park, South Australia, Australia, 3Repat General Hospital, Flinders University, Adelaide, Australia, 4Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 5The Health Observatory, The University of Adelaide, Adelaide, Australia

    Background/Purpose: Shoulder range of movement is integral to activities of daily living and the impact of pain on shoulder function has a significant effect on…
  • Abstract Number: 1083 • 2015 ACR/ARHP Annual Meeting

    Nationwide Trends in Hospitalization and in-Hospital Mortality Associated with Granulomatosis with Polyangiitis (GPA)

    Zachary Wallace1, John H. Stone2, Hyon K. Choi3, Na Lu3, Sebastian Unizony3 and Eli Miloslavsky4, 1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Massachusetts General Hopsital, Boston, MA

    Background/Purpose: Granulomatosis with polyangiitis (GPA) is associated with severe end-organ damage (e.g., renal failure) and treatment-related complications (e.g., severe infection) which often lead to hospitalization…
  • Abstract Number: 2412 • 2015 ACR/ARHP Annual Meeting

    Assessment and Comparison of Responsiveness of Four Patient Reported Outcome Measures to Assess Physical Function in Patients with Knee Osteoarthritis: WOMAC-PF Subscale Responds Best

    Elien A.M. Mahler1, Nienke Cuperus2, Johannes W J Bijlsma3, Thea Vliet Vlieland4, Frank H.J. van den Hoogen5, Alfons den Broeder5 and Cornelia H.M. van den Ende1, 1Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Rheumatology Department, Sint Maartenskliniek, Nijmegen, Netherlands, 3Rheumatology and Clinical Immunology, ARC Amsterdam; UMC Utrecht, Utrecht, Netherlands, 4Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Although physical function is one of the core outcome domains in knee osteoarthritis (OA), the ability of a measurement instrument to detect changes over…
  • Abstract Number: 1084 • 2015 ACR/ARHP Annual Meeting

    Improved Survival in Granulomatosis with Polyangiitis: A General Population-Based Study

    Zachary Wallace1, Sebastian Unizony2, Na Lu2, Hyon K. Choi2 and John H. Stone3, 1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 2Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA

    Background/Purpose: Granulomatosis with polyangiitis (GPA) is associated with an increased risk of mortality. Advances in diagnosis and treatment strategies are thought to improve outcomes in…
  • Abstract Number: 2899 • 2015 ACR/ARHP Annual Meeting

    Mortality Related to Pediatric Systemic Lupus Erythematosus: A Multiple Cause-of-Death Analysis in France

    laurent chiche1, sarah malaekah2, alexandre belot3, Brigitte Bader-Meunier4, gregoire rey5, Noémie Jourde-Chiche Sr.6 and mireille eb5, 1internal medicine, Hopital Europeen, Marseille, France, 2pediatry, CHU Lyon, Lyon, France, 3Pediatric Rheumatology, CHU lyon, Hospices Civils de Lyon, HFME, lyon, France, 4Hopital Necker-Enfants Malades, Paris, France, 5cepidc, paris, France, 6Nephrology, Aix-Marseille Université - APHM, Marseille, France

    Background/Purpose: Although regarded as a disease of adulthood, SLE is also seen in children, and is associated with an increased risk for aggressive clinical course…
  • Abstract Number: 1207 • 2015 ACR/ARHP Annual Meeting

    Predictive Utility of Anti- Citrullinated Peptide Antibodies and Rheumatoid Factor – a Retrospective Dataanalysis

    Miriam Gärtner, Mathias Schneeweiss, Josef S. Smolen and Klaus Machold, Department of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Antibody profiling encompassing rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPA) supports diagnosis in patients with Rheumatoid arthritis (RA). However, RF and ACPA are…
  • Abstract Number: 2943 • 2015 ACR/ARHP Annual Meeting

    Preliminary Population-Based Incidence and Prevalence Estimates of Systemic Lupus Erythematous from the Manhattan Lupus Surveillance Program

    Peter M. Izmirly1, Isabella Wan2, Sara Sahl1, Jill P. Buyon3, H. Michael Belmont4, Jane E. Salmon5,6, Joan M. Bathon7, Anca Askanase8, Laura Geraldino-Pardilla9, Yousaf Ali10, Ellen M. Ginzler11, Chaim Putterman12, Caroline Gordon13, Charles G. Helmick14 and Hilary Parton15, 1Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Rheumatology, New York University School of Medicine, New York, NY, 3Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4New York University School of Medicine, New York, NY, 5Dept of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 6Rheumatology, Hospital for Special Surgery, New York, NY, 7Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 8Columbia University College of Physicians & Surgeons, New York, NY, 9Division of Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 10Icahn School of Medicine at Mount Sinai, New York, NY, 11Medicine/Box 42, SUNY-Downstate, Brooklyn, NY, 12Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 13School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 14Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 15Bureau of Epidemiology Services, New York City Department of Health and Mental Hygiene, Long Island City, NY

    Background/Purpose: Given widely varying estimates of the incidence and prevalence of Systemic Lupus Erythematous (SLE) in the US and the absence of data for certain…
  • Abstract Number: 1209 • 2015 ACR/ARHP Annual Meeting

    Associations Between Rheumatoid Arthritis (RA)-Related Autoimmunity, Joint Symptoms, and Physical Activity in First-Degree Relatives without RA in a Prospective Cohort

    Jan M. Hughes-Austin1, Joachim H. Ix2, Samuel R. Ward3, Michael H. Weisman4, James R. O'Dell5, Ted R. Mikuls5, Jane H. Buckner6, Peter K. Gregersen7, Richard M. Keating8, Kevin D. Deane9, V. Michael Holers10 and Jill M. Norris11, 1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA, 3Radiology, Orthopaedic Surgery, and Bioengineering, University of California, San Diego, La Jolla, CA, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5University of Nebraska Medical Center, Omaha, NE, 6Benaroya Research Institute at Virginia Mason, Seattle, WA, 7Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Med Res, Manhasset, NY, 8Division of Rheumatology, Scripps Health, La Jolla, CA, 9Division of Rheumatology, U Colo Denver, Aurora, CO, 10Rheumatology Division, Univ of Colorado School of Med, Aurora, CO, 11University of Colorado Denver, Aurora, CO

    Background/Purpose: Physical activity in RA patients is significantly less than in counterparts without RA, and many live just above the muscle strength threshold needed for…
  • Abstract Number: 3163 • 2015 ACR/ARHP Annual Meeting

    The Smoking Paradox in the Development of Psoriatic Arthritis Among Psoriasis Patients

    Uyen Sa D.T. Nguyen1, Yuqing Zhang2, Na Lu3, Qiong Louie-Gao4, Jingbo Niu5, David T. Felson5, Michael P. Lavalley6, Thorvardur Love7,8, Maureen Dubreuil4, Jeffrey A. Sparks9, Elizabeth W. Karlson10 and Hyon K. Choi3, 1Orthopedics & Physical Rehabilation, Univerity of Massachusetts Medical School, Worcester, MA, 2Clinical Epidemilogy and Training Unit, Boston University School of Medicine, Boston, MA, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 6Biostatistics, Boston University, Boston, MA, 7Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 9Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, 10Rheumatology, Brigham & Women's Hospital, Boston, MA

    Background/Purpose: Smoking is a strong risk factor of psoriasis, but a previous study has suggested that smoking protects against the development of psoriatic arthritis (PsA)…
  • Abstract Number: 211 • 2015 ACR/ARHP Annual Meeting

    The Epidemiology of Gout: Marked Increase in Incidence and Comorbidities over 20 Years

    Mohanad Elfishawi1, Nour Zleik1, Zoran Kvrgic1, Clement J. Michet Jr.2, Cynthia S. Crowson3, Eric L. Matteson4 and Tim Bongartz1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Several studies have suggested that the prevalence of gout has increased over recent years. The majority of this data has been derived from insurance…
  • Abstract Number: 1450 • 2015 ACR/ARHP Annual Meeting

    Clostridium Difficile Infection-Associated Reactive Arthritis in a Pediatric Cohort

    Daniel B. Horton1,2,3, Brian L. Strom1,3, Mary E. Putt3, Carlos D. Rose2, David D. Sherry4 and Julia S. Sammons5, 1Rutgers Biomedical and Health Sciences, New Brunswick, NJ, 2Pediatrics, Nemours A.I. duPont Hospital for Children, Division of Pediatric Rheumatology, Thomas Jefferson University, Wilmington, DE, 3Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 4Pediatrics, Children's Hospital of Philadelphia, Division of Pediatric Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 5Pediatrics, Infection Prevention and Control, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The incidence of Clostridium difficile infection (CDI) has increased among children, and CDI is associated with significant morbidity and mortality. Cases of C. difficile…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology